About Foundation Medicine
Foundation Medicine is a Healthcare company based in Cambridge (United States) founded in 2010 by Todd Golub, Eric Lander, and Matthew Meyerson, and was acquired by Roche in January 2015. Genomics-based diagnostic tests for cancer are provided. Foundation Medicine has raised $96.5 million across 4 funding rounds from investors including Roche, Kleiner Perkins and The Gates Notes. Foundation Medicine has completed 2 acquisitions, including Lexent Bio and Saga Diagnostics. Its website foundationmedicine.com draws about 65 thousand monthly visits. Foundation Medicine offers products and services including FoundationOne CDx, FoundationOne Liquid CDx, FoundationOne RNA, and FoundationOne Heme. Its focus areas include Life Sciences, Oncology, In-Vitro Diagnostic Tests and Diversified. Its legal entity is FOUNDATION MEDICINE, INC. Its competitors include Guardant Health, ArcherDX and Natera; 3 of its 3 listed competitors have raised funding.
Company details
Provider of genomics-based diagnostics test for cancer. The companys clinical assays, FoundationOne for solid tumors, FoundationOne Heme for hematologic malignancies and sarcomas, and the liquid biopsy test FoundationACT provide a complete genomic profile of cancers, which oncologists can use to inform their treatment decisions. In addition, all tests provide an estimate of tumor mutational burden that enables oncologists to predict immunotherapy response as well.
- Headquarters Cambridge, United States
- Founders Todd Golub, Eric Lander, Matthew Meyerson
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website foundationmedicine.com
- Social LinkedIn X YouTube
- Acquired by Roche (Jan 2015)
- Legal Name Foundation Medicine, Inc.
- Total Equity Funding$96.5M (USD)
in 4 rounds
- Latest Funding Round$13.5M (USD), Series B
Jan 2013
- InvestorsRoche
& 8 more
- Investments & AcquisitionsLexent Bio
& 1 more
- Acquired byRoche
(Jan 2015)
Products & Services of Foundation Medicine
Foundation Medicine offers a comprehensive portfolio of products and services, including FoundationOne CDx, FoundationOne Liquid CDx, FoundationOne RNA, and FoundationOne Heme.
Test for analyzing tumor genes in advanced cancer patients
Test using cell-free DNA for cancer mutation detection
Test for detecting RNA fusions in cancer samples
Test for genomic profiling in blood cancers
Apps and channels of Foundation Medicine
its YouTube channel Foundation Medicine has 2.45K subscribers and 30 videos.
Videos from Foundation Medicine
The most watched videos on Foundation Medicine's YouTube channel, Foundation Medicine (2.45K subscribers). Click a video to play it here.
More on Foundation Medicine.
Funding Insights of Foundation Medicine
Foundation Medicine has successfully raised a total of $96.5M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $13.5 million completed in January 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $96.5M
- Total Rounds 4
- Last Round Series B — $13.5M
- First Round $7M
(Apr 2010)
- Investors Count 8
All 4 funding rounds of Foundation Medicine with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2013 | $13.5M | Series B | – | – | |
| Sep 2012 | $42.5M | Series B | – | Casdin Capital, Deerfield | |
| Aug 2011 | $33.5M | Series A | – | Google Ventures, Kleiner Perkins | |
| Apr 2010 | $7M | Series A | – | – | – |
9 investors in total: 9 institutional.
Investors in Foundation Medicine
Foundation Medicine has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Roche, Kleiner Perkins and The Gates Notes.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investing in Life Sciences sectors like Healthcare and Biotechnology. | casdincapital.com | |||
Venture capital funding is provided to early-stage life science companies. | thirdrockventures.com | Boston, United States | ||
Healthcare ecosystem is supported through investment and innovation by Deerfield. | deerfield.com | New York, United States | ||
Corporate backed venture capital fund investing in multiple sectors | gv.com | Mountain View, United States | ||
Venture capital firm investing in early-stage tech startups | 1972 | kleinerperkins.com | Menlo Park, United States | |
Corporate-backed venture capital firm focused on the healthcare sector | roche.com/venturefund.htm | |||
| gatesnotes.com | ||||
Operates as an employee-owned hedge fund focused on long/short equity strategies. | 2007 | redmilegroup.com | San Francisco, United States | |
Pharmaceuticals and diagnostics kits are developed for various diseases. | 1896 | roche.com | Basel, Switzerland |
Investor details for Foundation Medicine
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Foundation Medicine
415 people are tracked at Foundation Medicine (149 in leadership, 266 in team).
| Name | Role | Group |
|---|---|---|
Todd Golub | Co-Founder | Leadership |
Eric Lander | Co-Founder | Leadership |
Matthew Meyerson | Co-Founder | Leadership |
Cindy Perettie | Chairman Of The Board | Leadership |
Dionne Wells | VP Client Services And RTP Site Head | Leadership |
Jeffrey Ross | Medical Director | Leadership |
Jeffrey MacKay | Vice President, Facilities And Real Estate | Leadership |
Mariana Pinner | Associate Director, Internal Communications | Leadership |
Farida Peters-Abbadi | Vice President Of Marketing | Leadership |
Kai Brewer | Director, Biopharma Business Development | Leadership |
Elizabeth Dragolovich | Associate Director Regulatory Affairs | Leadership |
Daniel S. Lieber | Sr. Director, Computational Biology | Leadership |
Rachel von Staats | Senior Program Manager, Office Of The COO | Leadership |
Erin Regan | Director, Organizational Development | Leadership |
Paul D’Souza | Director, People Strategy | Leadership |
Winifred Lynn Swan | General Counsel And Chief Legal Officer | Leadership |
Nicholas Sumski | Director, Compliance Officer | Leadership |
Cyril Zarkoff | Director, Data Science - Commercial Insights | Leadership |
Vera Grossmann | Chief Operations Officer | Leadership |
Lazaro G. | Vp, Lab Operations And Site Head | Leadership |
395 more people are available in the full profile.
Complete people profiles for Foundation Medicine
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Foundation Medicine
Foundation Medicine has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Lexent Bio and Saga Diagnostics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Tests for circulating tumor DNA detection and analysis are offered. | sagadiagnostics.com | Lund, Sweden | 2016 | Apr 2026 | $595M | |
Bioinformatics and genomic science are provided for cancer diagnosis. | lexentbio.com | San Diego, United States | 2017 | Jun 2020 | •••• |
Complete acquisition details for Foundation Medicine
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Foundation Medicine
7 dated milestones of Foundation Medicine across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Foundation Medicine is founded.
- Funding First funding round of $7.0M.
- Funding Latest funding round, Series B, of $13.5M.
- IPO Lists on the stock exchange (IPO).
- Exit Acquired by Roche.
- Acquisition Acquires Lexent Bio.
- Acquisition Acquires Saga Diagnostics.
Competitors of Foundation Medicine
Foundation Medicine has 3 listed competitors in our database, 3 of them funded. They include Guardant Health, ArcherDX and Natera.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| guardanthealth.com | 2012 | Redwood, United States | $557.5M | 1,351 | Digital sequencing technology for cancer detection is developed. | |
| archerdx.com | 2013 | Boulder, United States | $152.6M | 429 | Molecular cancer diagnostic products are developed using patented AMP technology. | |
| natera.com | 2004 | Redwood, United States | $152.1M | 3,293 | Developer of cell-free DNA testing for oncology, women’s health, and organ health |
Detailed competitors of Foundation Medicine
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Foundation Medicine
The website of Foundation Medicine (foundationmedicine.com) receives about 65K visits a month and ranks #611,310 among all websites worldwide, #656 in Biotechnology and Pharmaceuticals.
- Monthly visits65K
▲ 60% vs previous month
- Unique visitors14.4K
per month
- Global rank#611,310
among all websites
- Category rank#656
Health · Biotechnology and Pharmaceuticals
- Bounce rate38%
- Pages per visit4.3
- Average visit3 min 49 sec
- DevicesDesktop 55% · Mobile 45%
Websites whose visitors overlap most with Foundation Medicine. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| genomichealth.com | 100% | 1.9K | #5,157,031 | View details | |
| prometrika.com | 84% | #2,751,954 | View details | ||
| vedantabio.com | 84% | 5.6K | #3,168,764 | View details | |
| agios.com | 83% | 21.8K | #1,284,134 | View details | |
| crisprtx.com | 80% | 120.2K | #365,059 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Foundation Medicine
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Foundation Medicine (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Foundation Medicine
Foundation Medicine was founded in 2010.
Foundation Medicine is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Foundation Medicine is a funded company, having raised a total of $96.5M across 4 funding rounds to date. The company's 1st funding round was a Series A of $7M, raised on Apr 2010.
Provider of genomics-based diagnostics test for cancer. The companys clinical assays, FoundationOne for solid tumors, FoundationOne Heme for hematologic malignancies and sarcomas, and the liquid biopsy test FoundationACT provide a complete genomic profile of cancers, which oncologists can use to inform their treatment decisions. In addition, all tests provide an estimate of tumor mutational burden that enables oncologists to predict immunotherapy response as well.
Foundation Medicine's top competitors include Guardant Health, Natera and ArcherDX.
Foundation Medicine offers FoundationOne CDx, FoundationOne Liquid CDx, FoundationOne RNA, and FoundationOne Heme.
Foundation Medicine has made 2 acquisitions, including Lexent Bio, and Saga Diagnostics.
Foundation Medicine has 9 investors. Key investors include Roche, Kleiner Perkins, The Gates Notes, Casdin Capital, and Third Rock Ventures.
Foundation Medicine operates through Foundation Medicine, Inc..
Yes. Foundation Medicine was acquired by Roche in January 2015.